ArticleClinical drug investigation2015

Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies.

Andreas Sashegyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.